News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Grant B. Walsh, Chairman of Medifocus, is Pleased to Announce the Appointment of Ernie Eves, QC, to the Board of Directors of Medifocus Inc.


3/29/2011 7:37:55 AM

To view the Social Media Release, click here: http://smr.newswire.ca/en/medifocus-inc/election-of-ernie-eves

TORONTO, March 29 /PRNewswire-FirstCall/ - Mr. Eves is the Former Premier of the Province of Ontario. As Premier, his responsibilities encompassed a budget of more than $70 billion and 65,000 employees. Prior to serving as Premier, he was Deputy Premier and Minister of Finance. He held numerous portfolios during his 24 years in public life which began as a member of the Provincial Legislature in 1981.

Mr. Eves has had a distinguished career in both the public and private sectors. Currently, he is the Executive Chairman of Jacob Securities Inc., an investment bank. He currently serves as an advisor and board member for several firms in Canada and the United States.

Ernie Eves is a graduate of Osgoode Hall Law School. He was called to the bar in 1972 and in 1983 was made a Queen's Counsel.

Medifocus Inc (TSX-V: MFS) owns a patented microwave focusing technology which can precisely target and concentrate microwave energy to destroy cancer tumours without damaging healthy tissue. It can be used alone or in conjunction with chemotherapy or radiation. Medifocus has built an Intellectual Property portfolio consisting of over 30 international patents. The Company has advanced the system for the treatment of breast cancer to the Phase III stage and has received approval from Health Canada and the FDA to begin the pivotal trial in Canada and the USA.

NOTE TO EDITORS: Media Assets accompanying this story are available as follows:

Photo: http://smr.newswire.ca/media/articles/1182/ernieeves.jpg

/NOTE TO PHOTO EDITORS: A photo accompanying this release is available at http://photos.newswire.ca. Images are free to accredited members of the media/

SOURCE Medifocus Inc.


Read at BioSpace.com


comments powered by Disqus
Medifocus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES